• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER Back to Search Results
Model Number ADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 11/25/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The customer contacted a siemens customer care center (ccc) and reported that discordant, falsely low complete blood count (cbc) parameters were obtained on two patient samples on an advia 2120i hematology system with dual aspirate autosampler.A siemens customer service engineer (cse) was dispatched to the customer site.The cse found the reagent leaking from the reagent tubing which was twisted and split.The tubing was replaced, the reagent block was cleaned, the analyzer was cleaned and the reagents in the system were primed.In a follow-up visit, the cse ran priming for the reagents and ran several precision runs.No outliers were observed during the runs after the reagent lines and pump were replaced.Quality controls (qc) were run and recovered within specifications.The cause of the discordant results was a combination of the damaged reagent tubing and the dirty reagent block.The system is performing according to specifications.No further evaluation of this device is required.
 
Event or Problem Description
Discordant, falsely low complete blood count (cbc) parameters were obtained on two patient samples on an advia 2120i hematology system with dual aspirate autosampler.The discordant parameters include white blood cells (wbc), red blood cells (rbc), hemoglobin (hgb), hematocrit (hct), and platelets (plt).The discordant results were not reported to the physician(s).The two patient samples were repeated for wbc, rbc, hgb, hct, and plt on an alternate advia 2120i hematology system, resulting higher.These results were reported, as the correct results, to the physician(s).There are no reports of patient intervention or adverse health consequences due to the discordant, falsely low white blood cells (wbc), red blood cells (rbc), hemoglobin (hgb), hematocrit (hct), and platelets (plt) results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER
Common Device Name
ADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591
MDR Report Key9500555
Report Number2432235-2019-00462
Device Sequence Number1878437
Product Code GKZ
UDI-Device Identifier00630414560045
UDI-Public00630414560045
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K102644
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberADVIA 2120I HEMATOLOGY SYSTEM WITH DUAL ASPIRATE AUTOSAMPLER
Device Catalogue Number10285573
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/26/2019
Initial Report FDA Received Date12/20/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-